Crohn Disease: all 1,923 studies

Page 9 of 20. Open to participants first (467), then studies with results posted, then the rest; newest registration first within each.

• A Study on the Associations of Toll-like Receptor 5 Gene Polymorphisms With Crohn's Disease in Chinese PatientsCompletedNCT07035678
• The Associations of Plasminogen Activator Inhibitor-1 Gene Polymorphisms With Crohn's Disease in Chinese PatientsCompletedNCT06935942
• A Study on the Associations Between Microribonucleic Acid Gene Polymorphisms and Crohn's DiseaseCompletedNCT06935929
• Role of IL 12 and IL 23 as Potential Biomarkers in Diagnosis of Early Crohn's DiseaseCompletedNCT06844565
• Autologous Stem Cells in the Management of Fistulating Perianal Crohn's DiseaseWithdrawnNCT06822686Not applicable
• Treatment of Rectovaginal Crohn's Fistula by Combination of TAAM Injection and Biological Plug PlacementSuspendedNCT06813768Not applicable
• Combined [18F]-FDG PET-MRI in Diagnostics and Surveillance of Small Bowel Crohn's DiseaseCompletedNCT06796959
• Changing the Future of Intestinal Failure in Intestinal Chronic Inflammation (INT-FAIL)Active, not recruitingNCT06777251Not applicable
• Long-term Remission After Ileorectal Anastomosis in Crohn's Disease.CompletedNCT06777043
• Assessing Interventions of Diet in IBDCompletedNCT06773182Not applicable
• Chronic Care Model on Symptom Status, Stress and Quality of Life in Individuals With Inflammatory Bowel DiseaseActive, not recruitingNCT06757231Not applicable
• Development and Validation of a New Paediatric Inflammatory Bowel Disease NUTrition Risk Score (PIBD-NUTS)Active, not recruitingNCT06723418
• Study Evaluating AZD7798 for Treatment in Crohn's Disease Patients With an IleostomyActive, not recruitingNCT06681324Phase 2
• A First-time in Human (FTIH) Study to Evaluate Safety, Tolerability, Pharmacokinetics and Target Engagement of GSK4528287 in Healthy ParticipantsActive, not recruitingNCT06681181Phase 1
• Prospective Cohort Establishment and Clinical Observation of Children With Crohn's DiseaseActive, not recruitingNCT06673134
• Evaluation of the Effectiveness of Kits Promonitor-IFX/ADL and Promonitor-Anti-IFX/ADL in Patients With IBDCompletedNCT06666569
• Exploring Multiple Self-Help Interventions to Promote Self-Efficacy and Overcome DisabilityCompletedNCT06646757Not applicable
• A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Crohn's Disease.TerminatedNCT06637631Phase 2
• Evaluation of the Efficacy and Safety of Endoscopic Dilatation and Biological Therapy in Intestinal Stenosis Due to CDStatus unknownNCT06603298
• Correlation Between RISANKIZUMAB's Trough Levels, Clinical and Biological Remission in Moderate to Severe Crohn's Disease: a Retrospective Multicentric StudyCompletedNCT06589895
• Digital Support for Mental Health Intervention in Patients With Inflammatory Bowel DiseaseCompletedNCT06575660Not applicable
• Mesentery Guide Identify Microscopic Clean Resection and Reduces Crohn's Endoscopic RecurrenceCompletedNCT06550843
• Role of Intestinal Ultrasound in Treat to Target Strategy in the Management of Inflammatory Bowel Disease : the IUS-TTT StudyActive, not recruitingNCT06534216
• Performance of Non-injected MR Enterography Compared to a Conventional MR Enterography Protocol With Contrast Agent InjectionCompletedNCT06526234
• Efficacy and Safety of Bowel Preparation for Patency Capsule in CD Patients Who Previously Failed Patency CapsuleStatus unknownNCT06515171
• Study on the Long-Term Risk of Recurrence of Anoperineal Fistula in Crohn's DiseaseCompletedNCT06514092
• Effect of Biologic Therapy on Surgical Outcomes for Perforated Crohn's PatientsCompletedNCT06511921
• Crohn's Disease - Inflammation and Microbial Proteolytic ActivityCompletedNCT06503081
• Retrospective Analysis of Systemic Glucocorticoid Mediated Long-term Effects, Patient Pathways and Economic Burden Across Multiple IndicationsCompletedNCT06488703
• The Innate Immune Response and Enteric Nervous System in Crohn's Disease.TerminatedNCT06485193
• Study of Oral Upadacitinib to Assess Change in Disease Activity and Adverse Events in Adult Participants With Ulcerative Colitis or Crohn's DiseaseCompletedNCT06459297
• Development and Validation of a Nomogram for Predicting Surgery in Newly-diagnosed Crohn's Disease: a Retrospective Cohort StudyCompletedNCT06457035
• Phase IIa Study Evaluating AZD7798 in Crohn's DiseaseActive, not recruitingNCT06450197Phase 2
• Real-life Use of the Crohn's Disease Exclusion Diet (CDED) in Adult Patients With Crohn's DiseaseCompletedNCT06448819Not applicable
• Efficacy and Safety Comparison of Upadacitinib and Vedolizumab in Second-line Treatment for Crohn's DiseaseCompletedNCT06446219
• Surgical Closure vs Anti-TNF in the Treatment of Perianal Fistulas in Crohn's Disease (PISA-II): a Comprehensive Cohort DesignCompletedNCT06441526Phase 3
• Prevalence and Factors Associated With Sleep Disorders in Inflammatory Bowel DiseaseCompletedNCT06439641Not applicable
• Positron Emission Tomography Study of Changes in [11C]AZ14132516 Uptake Following Administration of AZD7798 to Patients With Crohn's Disease.CompletedNCT06432764Phase 1
• Obsessive-compulsive Disorder, Depression and Anxiety Among Patients With Crohn's DiseaseCompletedNCT06429488
• Reducing Fatigue With CoQ10 Supplementation in Patients With Crohn's Disease StudyActive, not recruitingNCT06419335Early Phase 1
• Transmural Healing and Disease-Modifying Effect of Guselkumab in Crohn's Disease PatientsActive, not recruitingNCT06408935Phase 3
• Switching From Intravenous to Subcutaneous Infliximab in Adult Patients With Inflammatory Bowel DiseaseCompletedNCT06381518Not applicable
• Effects of Acupuncture on Abdominal Pain-related Intestinal Flora in Patients With Crohn's DiseaseCompletedNCT06375382Not applicable
• Effect of Acupuncture on the Microbiota-gut-brain Axis in Crohn's DiseaseCompletedNCT06364722Not applicable
• Capsule & Omics for pRedicting Exacerbation of Crohn's DiseaseActive, not recruitingNCT06362174
• Efficacy Classification Prediction of the Effects of Acupuncture on Abdominal Pain in Patients With Crohn's DiseaseCompletedNCT06352164Not applicable
• A Study to Assess the Concentrations of Risankizumab in the Breast Milk of Adult Lactating Women With Inflammatory Bowel DiseaseCompletedNCT06346288Phase 4
• Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severely Active Crohn's DiseaseActive, not recruitingNCT06332534Phase 3
• Observational Prospective Study to Identify Intestinal Microbial Profiles in Newly Diagnosed Crohn's Disease PatientsActive, not recruitingNCT06324591Not applicable
• Trial of Mirtazapine for Depression in IBDCompletedNCT06309472Phase 2
• PRecisiOn Microbiome Directed ExtensiOn of Anti-TNFα Crohn's Disease ThErapy in Children: The PROMOTE TrialActive, not recruitingNCT06301477Not applicable
• Endoscopic Relapse Risks Evaluation After Ileocolic Resection for Crohn's DiseaseCompletedNCT06299631
• VOICE-Early Response to Vedolizumab and IL-23 Antagonists in Participants With Crohn's Disease: A Prospective Observational StudyActive, not recruitingNCT06249555
• Phase 1 Study to Investigate OD-07656 in Healthy Adult ParticipantsCompletedNCT06206811Phase 1
• Intestinal Epithelial Fucosylation Affects the Efficacy of Ustekinumab in Crohn's DiseaseCompletedNCT06203158
• Analysis of Biologic Signatures in Crohn's Patients Undergoing SurgeryCompletedNCT06146335Not applicable
• An Observational Study to Assess Participant-Reported Real-World Experience of Risankizumab On-body Injector (OBI) for the Treatment of Crohn's Disease in Adult Participants in the United Kingdom (UK)CompletedNCT06126146
• Correlation of Cross Sectional Imaging and Small Intestinal Contrast Ultrasonography in Known Crohn's DiseaseCompletedNCT06125678Not applicable
• IBD-Sleep: A Pilot Study Looking at Changes in Sleep Timing and IBD SymptomsCompletedNCT06094608Not applicable
• A Retrospective Observational Study of Ustekinumab Among Bio-naive Participants With Crohn's Disease in ChinaCompletedNCT06082986
• Bowel Urgency in Inflammatory Bowel DiseaseCompletedNCT06069167
• A Study to Assess Adverse Events and Change in Disease Activity of Risankizumab Subcutaneous Induction Treatment for Moderately to Severely Active Crohn's Disease.Active, not recruitingNCT06063967Phase 3
• Phase I Clinical Study of ZL-82 TabletsCompletedNCT06055023Phase 1
• Positron Emission Tomography (PET) Study of Changes in [11C]AZ14132516 Uptake Following Administration of AZD7798 to Healthy Participants and Patients With Crohn's DiseaseCompletedNCT06053424Phase 1
• A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's DiseaseActive, not recruitingNCT06045754Phase 4
• Long-term Study of Endoscopic Treatment of Stenosis in Crohn´s DiseaseActive, not recruitingNCT06036680
• Impact of Telemonitoring in the Management of Complex IBD in Spain: M-TECCUCompletedNCT06031038Not applicable
• Improving Patient Outcomes Through the Implementation of an IBD Biologic Care PathwayWithdrawnNCT06030882Not applicable
• SMART-IBD App TrialCompletedNCT06023667Not applicable
• A Personalized Approach to Abdominal Pain in Irritable Bowel SyndromeActive, not recruitingNCT05998577Not applicable
• Effect of Grapes in Inflammatory Bowel DiseaseCompletedNCT05972694Not applicable
• RISE: A Remote Study of Insomnia Treatment in Crohn's DiseaseActive, not recruitingNCT05956158Not applicable
• Bowel Sounds Analysis in Paediatric Inflammatory Bowel Disease: Relationship With wPCDAICompletedNCT05955963Not applicable
• Safety and Efficacy of MBF-118 in Patients with Crohn DiseaseCompletedNCT05940558Phase 2
• Study to Assess Speed of Onset and Durability of Effectiveness of Upadacitinib in Adult Participants With Moderate to Severe Crohn's Disease (CD) in Real World Clinical Practice.Active, not recruitingNCT05930275
• Study Evaluating the Persistence, Efficacy and Tolerability of Methotrexate in Inflammatory Bowel Disease PatientsCompletedNCT05927064
• Exploration of the Activity of DNA Located Outside of Cellular Nucleus to Amplify Inflammation in Inflammatory Bowel Disease in Children Through Biological Pathway Cyclic GMP-AMP Synthase (cGAS) - Stimulator of Interferon Genes (STING)CompletedNCT05916274Not applicable
• The Evaluation of Injection Site Pain and Adherence in Patients Switching From a Low To High Concentration Adalimumab (AVT-02) Across Multiple Indications.CompletedNCT05913817
• Afimkibart (RO7790121) for the Treatment of Moderate to Severe Active Crohn's DiseaseActive, not recruitingNCT05910528Phase 2
• Histopathologic and Lymphocyte Subpopulations Evaluation of the Upper Gastrointestinal Tract of Crohn's DiseaseCompletedNCT05874349
• Effect of Vitamin D Supplementation on the Efficacy of Ustekinumab in the Treatment of Crohn's DiseaseCompletedNCT05867784
• An Observational Study to Assess Change in Disease Activity and Adverse Events In Adult Participants With Moderate to Severe Active Crohn's Disease (CD)Active, not recruitingNCT05841537
• Efficacy of Exclusive Enteral Nutrition in Adult Active Crohn's DiseaseCompletedNCT05815355
• Assessment of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ATH-063 in Healthy SubjectsCompletedNCT05807971Phase 1
• Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's DiseaseActive, not recruitingNCT05781152Phase 4
• The Impact of Medication Belief on Adherence to Infliximab in Patients With Crohn's DiseaseCompletedNCT05777616
• Contrast-enhanced Ultrasound in Patients With Crohn´s Disease and Food AllergyCompletedNCT05768971
• Treatment and Fate in Fistulizing Crohn's Disease in a Pediatric PopulationStatus unknownNCT05759104
• Comparative Accuracy of Transperineal Ultrasound (TPUS) Versus Magnetic Resonance Imaging (MRI) for the Assessment of Perianal Fistulae in Patients With Crohn's Disease (CD): a Prospective Observational Longitudinal Cohort StudyStatus unknownNCT05721794
• Assessment of Intestinal Inflammation by Infrared Thermography in Pediatric Crohn DiseaseCompletedNCT05710276Not applicable
• Regenerative Therapy With Autologous Stromal Vascular Fraction Derived Mesenchymal Stem Cells and Platelet-rich Plasma to Treat Complex Perianal DiseasesStatus unknownNCT05709717
• Effectiveness and Safety of Ustekinumab Intensification in Crohn's DiseaseStatus unknownNCT05705856
• VTX958 for the Treatment of Moderately to Severely Active Crohn's DiseaseTerminatedNCT05688852Phase 2
• 90Second IBD for the Improvement of Self Efficacy and Quality of Life in Inflammatory Bowel Disease PatientsWithdrawnNCT05686135Not applicable
• Non-Invasive Monitoring Through Bowel Ultrasound in Paediatric Inflammatory Bowel Disease StudyStatus unknownNCT05673278
• A Study to Evaluate the Long-Term Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's DiseaseActive, not recruitingNCT05668013Phase 2
• The Role of Gut Microbiome in Predicting Comorbidities and Complications in Children With Inflammatory Bowel DiseaseWithdrawnNCT05652491
• Quantify the Value of Transmural Inflammation in the Treatment of Crohn's Disease With Ustekinumab:an Analysis Based on Imaging ScienceCompletedNCT05642247
• Addressing Disability Effectively With Psychosocial TelemedicineCompletedNCT05635292Not applicable
• Evaluation of the SIMBA Capsule for Small Intestinal DysbiosisActive, not recruitingNCT05633706

← Crohn Disease overview